![](/img/cover-not-exists.png)
Pazopanib as Second-Line Treatment After Sunitinib or Bevacizumab in Patients With Advanced Renal Cell Carcinoma: A Sarah Cannon Oncology Research Consortium Phase II Trial
Hainsworth, John D., Rubin, Mark S., Arrowsmith, Edward R., Khatcheressian, James, Crane, Edward J., Franco, Luis A.Volume:
11
Language:
english
Journal:
Clinical Genitourinary Cancer
DOI:
10.1016/j.clgc.2013.04.006
Date:
September, 2013
File:
PDF, 391 KB
english, 2013